Su1038 INTRALESIONAL INJECTION OF ADALIMUMAB IN INTESTINAL STRICTURES OF PATIENTS WITH CROHN’S DISEASE: A RANDOMIZED, MULTICENTER, PROSPECTIVE CLINICAL TRIAL

Intestinal strictures in patients with Crohn’s disease (CD) represent a challenge due to their low response rate to medical therapy and high recurrence after endoscopic or surgical treatment. The intralesional injection of anti-TNF drugs is an option not fully investigated. The primary endpoint was to evaluate response rate to endoscopic dilation (ED) and intralesional injection of adalimumab (ADA) or placebo in patients with CD and intestinal...